1-Year Post-PharmD Early Talent Development Intern Program (Summer 2026-2027) - US Medical/Medical Operations - Education & Communication jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genentech · 4 hours ago

1-Year Post-PharmD Early Talent Development Intern Program (Summer 2026-2027) - US Medical/Medical Operations - Education & Communication

Genentech is a leading biotechnology company focused on patient access to medicines. They are seeking a highly motivated Post-PharmD intern to support the Medical Operations - Education & Communication team in creating impactful communications and content plans that align with medical priorities.

BiotechnologyLife ScienceManufacturing
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Gain a comprehensive understanding of US Medical activities through ownership of challenging and impactful business-critical projects while developing key scientific and professional skills necessary for a successful career in the pharmaceutical industry
Build clinical knowledge of the assigned molecule/product area(s) and create medical content that is compelling, compliant, and resonates with patients, HCPs, and/or access stakeholders (e.g. standard response letters, evidence submissions, Field Medical presentations, dossiers, etc)
Strengthen collaboration skills by working efficiently with all internal team members, partners, and stakeholders to meet the anticipated and known medical information needs of customers; break down silos to achieve results aligned with the content plans and the medical priorities
Deliver launch activities for new molecular entities and label expansions
As needed, provide medical review and input on the development/use of scientific and promotional materials and handle review processes in close partnership with medical partners, Commercial Regulatory, and Legal
Engage in short and long-term projects including technology initiatives (e.g. AI) that contribute to advancing business priorities, including a research project that is submitted and presented at a professional meeting such as the Drug Information Association

Qualification

Doctor of Pharmacy (PharmD)ClinicalAnalytical skillsContent creationPowerpointExcelWordEffective communicationInterpersonal skillsTime managementOrganizational skillsCollaboration skills

Required

Effective verbal, written, interpersonal and presentation skills
Strong clinical and analytical skills with clear examples of the ability to engage in independent work in collaborative and multidisciplinary environments
Strong time management, prioritization, and organizational skills; self‐starter and highly motivated; demonstrates flexibility, courage, and drive for results
Impeccable ethics and integrity; honest, direct, and open communications
Proficiency in the following: Powerpoint, Excel, Word
Doctor of Pharmacy (PharmD) degree from an ACPE-accredited institution before July 1st, 2026
Must be within two years Post-PharmD

Preferred

Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Prior work experience, with experience in pharmaceutical industry or managed care setting preferred
Experience creating compelling content and storytelling delivered via various media (e.g. creating presentations, web content, emails, videos, podcasts, infographics, etc)
Experience with projects leveraging new technologies (e.g. AI/systems/programs)

Benefits

Paid holiday time off benefits

Company

Genentech

company-logo
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.

H1B Sponsorship

Genentech has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)

Funding

Current Stage
Public Company
Total Funding
unknown
2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown

Leadership Team

leader-logo
Ashley Magargee
Chief Executive Officer
linkedin
leader-logo
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
linkedin
Company data provided by crunchbase